Publications of Udo Reichl

Küchler, J.; Opitz, P.; Jordan, I.; Genzel, Y.; Benndorf, D.; Reichl, U.: Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Pelz, L.; Dogra, T.; Rüdiger, D.; Boehme, J.; Kershaw, O.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 28th ESACT Meeting, Edinburgh (Scotland) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: A two-dimensional model to predict coinfection of influenza A virus with defective interfering particles in tissue-like systems. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Implementation of Quality by Design Principles for Influenza A Virus Production. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Zuniga-Banuelos, F. J.; Hoffmann, M.; Reichl, U.; Rapp, E.: In-depth N glycoproteomic analysis reveals strategies to elucidate unanticipated N glycans in the low-abundant human blood plasma N glycoproteome. 23^rd Human Proteome Organization World Congress (HUPO World Congress), Dresden (Germany) (2024)

Alcalá Orozco, E. A.; Fiebig, T.; Mahour, R.; Grote, V.; Rexer, T.; Reichl, U.: Development of a cell-free multi-enzyme cascade for the synthesis of CDP-glycerol. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 8^th European Congress of Virology, Gdańsk (Poland) (2023)

Hoang Son, T.; Lange, F.; Rexer, T.; Reichl, U.: Multi-gram-scale production of uridine nucleotide sugars by in-vitro multi-enzyme cascades. GlycoBioTec 2023, Berlin, Germany (2023)

Hoang Son, T.; Wormstall, S.-T.; Rexer, T.; Reichl, U.: Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approach. GlycoBioTec 2023, Berlin, Germany (2023)

Juárez-Osorio, M.; Darr, A.; Volckmar, J.; Bruder, D.; Rexer, T.; Reichl, U.: Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein. GlycoBioTec 2023, Berlin, Germany (2023)

Küchler, J.; Opitz, P.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of viral proteins during single-round replication of vaccine producer cell lines. 32^nd Annual Meeting of the Society for Virology (GfV) , Ulm (Germany) (2023)

Küchler, J.; Opitz, P.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell lines. 16^th PEACe (Protein Expression in Animal Cells) Conference, Sitges (Spain) (2023)

Lemke, G.; Zuniga-Banuelos, F. J.; Grote, V.; Hoffmann, M.; Rapp, E.; Reichl, U.: N-glycan Sulfation on Human IgA: In-Depth N-glycoproteomic Analyses of Sulfated N-glycan Site-Specificity and Distribution on Human IgA Isotypes. GlycoBioTec 2023, Berlin, Germany (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Hein, M. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Marichal-Gallardo, P.; Hein, M. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo Studies. Himmelfahrtstagung on Bioprocess Engineering 2023, Weimar (Germany) (2023)